Guido Grandi, holder of Ph.D. degree, joined Farmitalia Carlo Erba, Milan, Italy, and moved as a Visiting Scientist to the Public Health Research Institute in New York, USA, where he worked on the genetics and molecular biology of Gram-positive organisms. In 1981, he became Director of the Biotechnology Department of EniRicerche, the Centralized Research Company of ENI, where he developed a number of biotechnological processes based on recombinant bacterial strains, including human growth hormone, interleukins, and industrial enzymes. In 1995, Guido Grandi joined Chiron Vaccines as Head of the Biochemistry and Molecular Biology Unit, where he has been exploiting genomic and proteomic technologies in new vaccine discovery. In 2002, Dr. Grandi was promoted to be the Vice President of Chiron Vaccines (Novartis Vaccines since April 2006). Currently, he is Senior Project Leader, with a number of important vaccine projects under his responsibility. He is also Member of the Novartis Vaccines Siena board of directors. Since 2010, Guido Grandi holds the position of Professor of Microbiology, Immunology, and Vaccinology at the University of Trento, Italy. Guido Grandi is inventor/coinventor of 99 patent families that have so far generated 428 patents granted in different countries and author/coauthor of more than 150 publications in international, peer-reviewed journals.
Biography Updated on 27 December 2012